SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.62+0.1%Dec 24 12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (26651)11/23/1998 6:56:00 PM
From: Machaon  Read Replies (1) of 32384
 
From the news release:

<< A Phase II trial with Targretin gel for the treatment of patients with actinic keratoses and Phase IIb studies in patients with ovarian and head and neck cancers have been completed. >>

Are there any results published from these "completed" phase II studies? I would think that if there were significant results, something would've been published by now.

Thanks, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext